BACKGROUND: Considerable progress has been made in our understanding of the biological basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of the subject by MASCC/ISOO was published in 2007; consequently, an update is timely. METHODS: Panel members reviewed the biomedical literature on mucositis pathobiology published between January 2005 and December 2011. RESULTS: Recent research has provided data on the contribution of tissue structure changes, inflammation and microbiome changes to the development of mucositis. Additional research has focused on targeted therapy-induced toxicity, toxicity clustering and the investigation of genetic polymorphisms in toxicity prediction. This review paper summarizes the recent evidence on these aspects of mucositis pathobiology. CONCLUSION: The ultimate goal of mucositis researchers is to identify the most appropriate targets for therapeutic interventions and to be able to predict toxicity risk and personalize interventions to genetically suitable patients. Continuing research efforts are needed to further our understanding of mucositis pathobiology and the pharmacogenomics of toxicity.
BACKGROUND: Considerable progress has been made in our understanding of the biological basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of the subject by MASCC/ISOO was published in 2007; consequently, an update is timely. METHODS: Panel members reviewed the biomedical literature on mucositis pathobiology published between January 2005 and December 2011. RESULTS: Recent research has provided data on the contribution of tissue structure changes, inflammation and microbiome changes to the development of mucositis. Additional research has focused on targeted therapy-induced toxicity, toxicity clustering and the investigation of genetic polymorphisms in toxicity prediction. This review paper summarizes the recent evidence on these aspects of mucositis pathobiology. CONCLUSION: The ultimate goal of mucositis researchers is to identify the most appropriate targets for therapeutic interventions and to be able to predict toxicity risk and personalize interventions to genetically suitable patients. Continuing research efforts are needed to further our understanding of mucositis pathobiology and the pharmacogenomics of toxicity.
Authors: Barbara A E de Koning; Jolanda M van Dieren; Dicky J Lindenbergh-Kortleve; Maria van der Sluis; Tetsuya Matsumoto; Keizo Yamaguchi; Alexandra W Einerhand; Janneke N Samsom; Rob Pieters; Edward E S Nieuwenhuis Journal: Int Immunol Date: 2006-04-24 Impact factor: 4.823
Authors: Noor Al-Dasooqi; Joanne M Bowen; Rachel J Gibson; Richard M Logan; Andrea M Stringer; Dorothy M Keefe Journal: Int J Exp Pathol Date: 2011-04-05 Impact factor: 1.925
Authors: Luca D Prisciandaro; Mark S Geier; Ross N Butler; Adrian G Cummins; Gordon S Howarth Journal: Cancer Biol Ther Date: 2011-04-01 Impact factor: 4.742
Authors: B A Carneiro-Filho; I P F Lima; D H Araujo; M C Cavalcante; G H P Carvalho; G A C Brito; V Lima; S M N Monteiro; F N Santos; R A Ribeiro; A A M Lima Journal: Dig Dis Sci Date: 2004-01 Impact factor: 3.199
Authors: Richard M Logan; Andrea M Stringer; Joanne M Bowen; Ann S-J Yeoh; Rachel J Gibson; Stephen T Sonis; Dorothy M K Keefe Journal: Cancer Treat Rev Date: 2007-05-15 Impact factor: 12.111
Authors: Philip Riley; Anne-Marie Glenny; Helen V Worthington; Anne Littlewood; Luisa M Fernandez Mauleffinch; Jan E Clarkson; Martin G McCabe Journal: Cochrane Database Syst Rev Date: 2017-11-28
Authors: Judith A E M Zecha; Judith E Raber-Durlacher; Raj G Nair; Joel B Epstein; Sharon Elad; Michael R Hamblin; Andrei Barasch; Cesar A Migliorati; Dan M J Milstein; Marie-Thérèse Genot; Liset Lansaat; Ron van der Brink; Josep Arnabat-Dominguez; Lisette van der Molen; Irene Jacobi; Judi van Diessen; Jan de Lange; Ludi E Smeele; Mark M Schubert; René-Jean Bensadoun Journal: Support Care Cancer Date: 2016-03-17 Impact factor: 3.603
Authors: Stéfanie Thieme; Julia Turra Ribeiro; Bernardo Gindri Dos Santos; Renata de Almeida Zieger; Mara Luana Batista Severo; Marco Antonio Trevizani Martins; Cristiane Matté; Manoela Domingues Martins Journal: Support Care Cancer Date: 2019-06-04 Impact factor: 3.603
Authors: Karin Garming Legert; Georgios Tsilingaridis; Mats Remberger; Olle Ringdèn; Anders Heimdahl; Tülay Yucel-Lindberg; Göran Dahllöf Journal: Support Care Cancer Date: 2014-11-30 Impact factor: 3.603
Authors: Ysabella Z A Van Sebille; Romany Stansborough; Hannah R Wardill; Emma Bateman; Rachel J Gibson; Dorothy M Keefe Journal: Curr Oncol Rep Date: 2015-11 Impact factor: 5.075
Authors: S Weischendorff; K Kielsen; H Sengeløv; K Jordan; C H Nielsen; A E Pedersen; L P Ryder; A Juul; K G Müller Journal: Bone Marrow Transplant Date: 2017-04-24 Impact factor: 5.483
Authors: Marianne J Hjermstad; Mia Bergenmar; Kristin Bjordal; Sheila E Fisher; Dirk Hofmeister; Sébastien Montel; Ourania Nicolatou-Galitis; Monica Pinto; Judith Raber-Durlacher; Susanne Singer; Iwona M Tomaszewska; Krzysztof A Tomaszewski; Irma Verdonck-de Leeuw; Noam Yarom; Julie B Winstanley; Bente B Herlofson Journal: Support Care Cancer Date: 2016-04-25 Impact factor: 3.603